Cormorant Asset Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Cormorant Asset Management’s Portfolio MRNS Stock Details MRNS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell
2024 Q1	$29.4M	Hold
2023 Q4	$35.3M	Buy
2023 Q3	$21.1M	Buy
2018 Q4	–	Sell
2018 Q3	$3M	Sell
2018 Q2	$3.38M	Hold
2018 Q1	$1.83M	Sell
2017 Q4	$4.08M	Buy